Cargando…

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?

The ongoing debate regarding a potential role for hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer represents an excellent example of the rarely publicly discussed fundamental clash between the requirements of evidence-based medicine and the roles of clinical innovation...

Descripción completa

Detalles Bibliográficos
Autor principal:	Markman, Maurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2016
Materias:	Controversies in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861367/ https://www.ncbi.nlm.nih.gov/pubmed/27009940 http://dx.doi.org/10.1634/theoncologist.2015-0486

Ejemplares similares

Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control
por: Petrillo, Marco, et al.
Publicado: (2016)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009)

Promoting Physical Activity in Pediatric Oncology. Where Do We Go from Here?
por: Viña, Carolina Chamorro, et al.
Publicado: (2013)

WHERE DO WE GO FROM HERE?
por: Kuruvilla, K.
Publicado: (1994)

Where do we go from here
por: Ranganathan, Kannan
Publicado: (2012)

Where Do we Go from Here …
por: Dickson-Deane, Camille
Publicado: (2020)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
por: Yoon, Won-Hee, et al.
Publicado: (2023)

DECRA…Where do we go from here?
por: Torres, Roland
Publicado: (2012)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses
por: Souadka, Amine, et al.
Publicado: (2022)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

The BENEFIT Trial: Where Do We Go from Here?
por: Pecoul, Bernard, et al.
Publicado: (2016)

Hemofiltration in sepsis: where do we go from here?
por: Kellum , John A, et al.
Publicado: (2000)

Calibration Research: Where Do We Go from Here?
por: Bol, Linda, et al.
Publicado: (2012)

Combination immunotherapy: Where do we go from here?
por: Overacre, Abigail E., et al.
Publicado: (2015)

Developmental Dyslexia: Where Do We Go from Here?
por: Engelhardt, Paul E.
Publicado: (2020)

COVID-19: where do we go from here?
por: The Lancet
Publicado: (2021)

Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018)

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?
por: Dhawan, Annika, et al.
Publicado: (2022)

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
por: Bai, Yun, et al.
Publicado: (2023)

Addressing bioterrorist threats: where do we go from here?
por: Hamburg, M A
Publicado: (1999)

Exploring the Promise of Resveratrol: Where Do We Go From Here?
por: Crandall, Jill P., et al.
Publicado: (2013)

An Ultra-rare Disease? Where Do We Go from Here?
por: Irvine, Glenn, et al.
Publicado: (2013)

Self-tracking the microbiome: where do we go from here?
por: Gimbert, Carine, et al.
Publicado: (2015)

Review of the Transgender Literature: Where Do We Go from Here?
por: Wanta, Jonathon W., et al.
Publicado: (2017)

Gene Therapy and Hemophilia: Where Do We Go from Here?
por: Bolous, Nancy S, et al.
Publicado: (2022)

Cannabis legalization in the US. Where do we go from here?
por: Martins, Silvia S., et al.
Publicado: (2022)

Early intervention in psoriasis: Where do we go from here?
por: Felix, Paulo Antônio Oldani, et al.
Publicado: (2022)

Drug misuse in India: Where do we stand & where to go from here?
por: Avasthi, Ajit, et al.
Publicado: (2019)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ramirez, Maria F., et al.
Publicado: (2023)

Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?
por: Helm, C. William
Publicado: (2015)

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?
por: Spiliotis, John
Publicado: (2020)

Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
por: Kim, S.I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7mdiee66np89chbohks96iar4b